https://www.zonebourse.com/cours/action/NANEXA-AB-107634505/actualite/Nanexa-AB-annonce-que-la-demande-d-essai-clinique-pour-l-etude-de-phase-I-de-NEX-22-a-ete-evalu-45606905/?utm_source=telegram&utm_medium=social&utm_campaign=share